Stage 5 — Take action. After acute stabilization of neuroleptic malignant syndrome caused by haloperidol, the client's temperature and rigidity are improving, but auditory hallucinations persist. The psychiatry and medical teams meet with the client and family to plan future antipsychotic treatment. Which elements should the nurse support in the recurrence-prevention plan? Select all that apply.

Quick answer
Support a delay of at least 2 weeks after resolution, a low-dose lower-potency agent titrated slowly, and hydration with temperature and vital-sign monitoring during any restart (2, 3, 6).

Why this is correct
Most clients who need antipsychotics after NMS can be rechallenged safely if risk factors are controlled. Recurrence risk is highest with early rechallenge, high-potency agents, rapid dose escalation, parenteral or depot routes, and dehydration, which are the exact factors present when this client's NMS began (repeated IM doses, rapid escalation, poor intake).

Easy analogy or mental picture
Think of re-entering cold water after a cramp: you wait until the muscle has fully recovered, go in slowly and shallowly, and have someone watching.

Memory hook
Rechallenge rule: Wait, go Weak (low potency), go Slow, stay Wet.

NCLEX decision rule
Plan antipsychotic rechallenge by reversing the risk factors that caused the original episode: timing, potency, rate of escalation, route, and hydration.

Why the other choices are wrong
A long-acting injectable is tempting because adherence matters in psychosis, but a depot cannot be withdrawn if NMS recurs, so oral agents are used for rechallenge. Adding lithium sounds like a dose-sparing strategy, but concurrent lithium is a recognized risk factor for NMS and does not make rechallenge safer. Benztropine with the first dose is tempting because anticholinergics prevent antipsychotic dystonia and EPS rigidity, but they do not prevent NMS and their anticholinergic effect reduces sweating and heat loss.